Anti-RPA was found in 1.4% (4 of 276) in SLE (includes SLE-overlap syndrome) but not in other systemic autoimmune rheumatic diseases such as SSc (n = 47), PM/DM (n = 43), and RA (n = 35). Here, RPA1 is linked to systemic sclerosis.